Chelsea Caspell‐Garcia

Author

Also Known As

Alice S. Chen-Plotkin, C. Caspell-Garcia, Caspell-Garcia, Chelsea, Catherine Kopil, Chelsea Caspell-Garcia, Chelsea Caspell‐Garcia, Chelsea J. Caspell-Garcia, Chelsea J. Caspell‐Garcia, Christopher Hobbick, Gena Antonopoulos

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Iowa Northwestern University University of Pennsylvania Institute for Neurodegenerative Disorders Michael J. Fox Foundation

About

Chelsea Caspell‐Garcia is an author at University of Iowa specializing in medicine, neurology, and parkinson disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	895
2	Health Sciences	1	1	83
3	Public Health	1	1	171
4	Social Sciences	1	1	12
5	Biostatistics	1	1	171

Chelsea Caspell‐Garcia

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Annals of Clinical and Translational Neurology	2018	633
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, The Lancet Neurology Neurodegenerative DiseasesDisease ProgressionParkinson DiseaseNeurologyMedicine	2023	618
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia, Movement Disorders	2015	296
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease Marco J. Russo, Christina D. Orrú, Luis Concha‐Marambio, Acta Neuropathologica Communications	2021	241
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort Tanya Simuni, Andrew Siderowf, Shirley Lasch, Movement Disorders	2018	199
How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort? Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Parkinsonism & Related Disorders Disease ProgressionDisease SubtypesParkinson DiseasePpmi CohortGenetic Epidemiology	2016	171
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Neurology	2017	149
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease Chelsea Caspell‐Garcia, Tanya Simuni, Duygu Tosun, PLoS ONE	2017	147
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease Lana M. Chahine, Thomas G. Beach, Michael C. Brumm, Neurology	2020	146
Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Movement Disorders	2019	134

Page 1